HKU Scholars Hub: Browsing DSpace

Browsing by Author Meadows, KL

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 4 of 4

	Title	Author(s)	Issue Date
	A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer Journal:The Oncologist	Vlahovic, G Meadows, KL Hatch, AJ Jia, J Nixon, A Uronis, HE Morse, MA Selim, MA Crawford, J Riedel, R Zafar, SY Howard, LA O'Neill, M Meadows, JJ Haley, ST Arrowood, CC Rushing, C Pang, H Hurwitz, HI	2018
	A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas Journal:Oncologist	Uronis, HE Bendell, JC Altomare, I Blobe, GC David Hsu, S Morse, MA Pang, H Yousuf Zafar, S Conkling, P Favaro, J Arrowood, CC Cushman, SM Meadows, KL Brady, JC Nixon, AB Hurwitz, HI	2013
	Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors Journal:Invest New Drugs	Rangwala, F Bendell, JC Kozloff, MF Arrowood, CC Dellinger, A Meadows, J Tourt-Uhlig, S Murphy, J Meadows, KL Starr, A Broderick, S Brady, JC Cushman, SM Morse, MA Uronis, HE Hsu, SD Zafar, SY Wallace, J Starodub, AN Strickler, JH Pang, HMH Nixon, AB Hurwitz, HI	2014
	Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer Journal:Investigational New Drugs	Strickler, JH McCall, S Nixon, AB Brady, JC Pang, H Rushing, C Cohn, A Starodub, A Arrowood, C Haley, S Meadows, KL Morse, MA Uronis, HE Blobe, GC Hsu, SD Zafar, SY Hurwitz, HI	2014

Showing results 1 to 4 of 4